We are a spinoff company of the Foundation for Research and Technology - Hellas (FORTH) and the University of Crete.
We develop advanced patient-tailored treatments using proprietary technologies
Our Technology
We provide expertise in
-
precision biofabrication
-
biomaterial development
-
stem cell culture and differentiation
-
cell and animal models of neurodegeneration
-
animal models of CNS injury
-
imaging
-
robotics
Neuroimplants
Novel treatments for Central Nervous System Injuries consisting of potent Stem Cells inside bioactive ​biomaterials
Relevant Publications
-
Kourgiantaki A., et al. Neural stem cell delivery via porous collagen scaffolds promotes neuronal differentiation and locomotion recovery in spinal cord injury. NPJ Regen Med 5:12, 2020. doi: 10.1038/s41536-020-0097-0.
-
Georgelou K., et al. Microneurotrophin BNN27 Reduces Astrogliosis and Increases Density of Neurons and Implanted Neural Stem Cell-Derived Cells after Spinal Cord Injury. Biomedicines 11(4):1170, 2023. doi: 10.3390/biomedicines11041170.
-
Georgelou K., et al. Delivery of Microneurotrophin BNN27 via Collagen Glycosaminoglycan Scaffold - FmocFF Hydrogel Grafts Promotes Neuroprotection after Optic Nerve Injury. J Biomed. Mat. Res. B: 114(1):e70013, 2026. doi: 10.1002/jbmb.70013
Our Team
Achilleas Gravanis, CEO, co-founder
Former Professor of Pharmacology, Medical School, University of Crete. Former affiliated faculty member, IMBB-FORTH. Affiliated Professor, Faculty of Pharmacy, Northeastern University, USA. Affiliated Principal Investigator, Emulate Co, USA. Venture partner, BigPi Ventures. Venture partner, Olivetree Venture Capital. Served as member of the Biomedical Research Program Committee of the European Commission. Co-founder of biotechnology spinoff BioNature Ltd.
Dimitrios Tzeranis, CSO, co-founder
Assistant Professor, Material Science & Engineering, University of Crete. Affiliated Faculty Member, IMBB-FORTH. Founder of FORTH/UoC Biomaterials & Medical Devices Lab.
Ioannis Charalampopoulos, COO, co-founder
Professor of Pharmacology, Medical School, University of Crete & Clinical Pharmacology Laboratory, University General Hospital. Collaborating Faculty Member, IMBB-FORTH. Fellow, Dept of Neuroscience, Karolinska Medical School. Ex Director, Graduate Program in Neurosciences, Medical School, University of Crete. Partner, BioNature Ltd.
Gregory Roumeliotis, Chief Strategy Officer
​​Precision Medicine Go-to-Market Strategist with major background in Health Technology Assessment and tech trasnfers. Multiomics / genomics - NGS technologies integration expert.
Pioneer in the establishment and development of biobanking & cell therapy preclinical services.
Emmanuel Stratakis, co-founder
Director, IESL-FORTH. Head, Ultrafast Laser Micro- and Nano- processing laboratory. Director, FORTH European Nanoscience Facility. National expert in the High-Level Group of EU on Nanotechnologies, Advanced Materials, Biotechnology, Advanced Manufacturing and Processing. Member, COST Scientific Committee. Founder and CEO, Biomimetic (FORTH spinoff).
Konstantinos Fotakis, co-founder
Professor Emeritus of Physics; University of Crete. Distinguished Member; FORTH.
Former Alternate Minister for Research and Innovation (January 2015 to July 2019).